Hennion & Walsh Asset Management, Inc. Celcuity Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.69 Billion
- Q4 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 190,933 shares of CELC stock, worth $17.6 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
190,933
Previous 171,354
11.43%
Holding current value
$17.6 Million
Previous $8.42 Million
109.56%
% of portfolio
0.66%
Previous 0.33%
Shares
7 transactions
Others Institutions Holding CELC
# of Institutions
198Shares Held
37.9MCall Options Held
574KPut Options Held
205K-
Baker Bros. Advisors LP New York, NY7.92MShares$732 Million3.17% of portfolio
-
Perceptive Advisors LLC New York, NY2.96MShares$273 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$211 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD2.14MShares$198 Million6.59% of portfolio
-
Morgan Stanley New York, NY1.51MShares$140 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $1.38B
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...